Myrcene-13C3

Myrcene-13C3 is 13C labeled Myrcene (HY-N0803) . Myrcene (β-Myrcene) is a type of aromatic compound that inhibits TNFα and NF-κB activity. Myrcene has anti-invasive action, inhibits cell cycle, and leads to cancer cell apoptosis. Myrcene has strong blood protection effect, anti-inflammation, and anti-inflammatory activity[1][2][3][4][5].

Product Specifications

Product Name Alternative

β-Myrcene-13C3

UNSPSC

12352211

Target

Isotope-Labeled Compounds; NF-κB

Type

Isotope-Labeled Compounds

Related Pathways

NF-κB; Others

Applications

COVID-19-immunoregulation

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/myrcene-13c3.html

Solubility

10 mM in DMSO

Smiles

C=CC(CC/C=[13C]([13CH3])/[13CH3])=C

Molecular Formula

C7 13C3H16

Molecular Weight

139.21

References & Citations

[1]Eunson Hwang, et al. Myrcene, an Aromatic Volatile Compound, Ameliorates Human Skin Extrinsic Aging via Regulation of MMPs Production. Am J Chin Med. 2017;45 (5) :1113-1124.|[2]Jeong-Ho Lee, et al. Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells. Journal of the Korean Society for Applied Biological Chemistry volume 58, pages563–569.|[3]Bai X, et al. Myrcene exhibits antitumor activity against lung cancer cells by inducing oxidative stress and apoptosis mechanisms[J]. Natural Product Communications, 2020, 15 (9) : 1934578X20961189.|[4]Islam AUS, et al. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model. Molecules. 2020 Sep 30;25 (19) :4492.|[5]Kumar R, et al. Ameliorative effect of myrcene in mouse model of Alzheimer's disease. Eur J Pharmacol. 2021 Nov 15;911:174529.|[6]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.